Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

The RND1 Small GTPase: Main Functions and Emerging Role in Oncogenesis.

Mouly L, Gilhodes J, Lemarié A, Cohen-Jonathan Moyal E, Toulas C, Favre G, Sordet O, Monferran S.

Int J Mol Sci. 2019 Jul 24;20(15). pii: E3612. doi: 10.3390/ijms20153612. Review.

2.

Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma.

Bilal F, Montfort A, Gilhodes J, Garcia V, Riond J, Carpentier S, Filleron T, Colacios C, Levade T, Daher A, Meyer N, Andrieu-Abadie N, Ségui B.

Front Pharmacol. 2019 Apr 30;10:443. doi: 10.3389/fphar.2019.00443. eCollection 2019.

3.

Proteomic evidence of specific IGKV1-8 association with cystic lung light chain deposition disease.

Camus M, Hirschi S, Prevot G, Chenard MP, Mal H, Stern M, Reynaud-Gaubert M, Gilhodes J, Burlet-Schiltz O, Brousset P, Colombat M.

Blood. 2019 Jun 27;133(26):2741-2744. doi: 10.1182/blood.2019898577. Epub 2019 Apr 9.

PMID:
30967366
4.

Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner.

Bianco JN, Bergoglio V, Lin YL, Pillaire MJ, Schmitz AL, Gilhodes J, Lusque A, Mazières J, Lacroix-Triki M, Roumeliotis TI, Choudhary J, Moreaux J, Hoffmann JS, Tourrière H, Pasero P.

Nat Commun. 2019 Feb 22;10(1):910. doi: 10.1038/s41467-019-08886-8.

5.

Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas.

Garandeau D, Noujarède J, Leclerc J, Imbert C, Garcia V, Bats ML, Rambow F, Gilhodes J, Filleron T, Meyer N, Brayer S, Arcucci S, Tartare-Deckert S, Ségui B, Marine JC, Levade T, Bertolotto C, Andrieu-Abadie N.

Mol Cancer Ther. 2019 Feb;18(2):289-300. doi: 10.1158/1535-7163.MCT-17-1141. Epub 2018 Nov 27.

PMID:
30482853
6.

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.

Keller L, Guibert N, Casanova A, Brayer S, Farella M, Delaunay M, Gilhodes J, Martin E, Balagué G, Favre G, Pradines A, Meyer N.

Acta Derm Venereol. 2019 Feb 1;99(2):206-210. doi: 10.2340/00015555-3080.

7.

RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.

Boyrie S, Delmas C, Lemarié A, Lubrano V, Dahan P, Malric L, Luis J, Gilhodes J, Tosolini M, Mouly L, Lehmann M, Toulas C, Cohen-Jonathan Moyal E, Monferran S.

Oncotarget. 2018 Sep 18;9(73):33788-33803. doi: 10.18632/oncotarget.26082. eCollection 2018 Sep 18.

8.

Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.

Evrard SM, Péricart S, Grand D, Amara N, Escudié F, Gilhodes J, Bories P, Traverse-Glehen A, Dubois R, Brousset P, Parrens M, Laurent C.

Haematologica. 2019 Apr;104(4):e154-e157. doi: 10.3324/haematol.2018.198572. Epub 2018 Oct 11. No abstract available.

9.

Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.

Malric L, Monferran S, Delmas C, Arnauduc F, Dahan P, Boyrie S, Deshors P, Lubrano V, Da Mota DF, Gilhodes J, Filleron T, Siegfried A, Evrard S, Kowalski-Chauvel A, Moyal EC, Toulas C, Lemarié A.

Mol Cancer Res. 2019 Feb;17(2):384-397. doi: 10.1158/1541-7786.MCR-18-0386. Epub 2018 Sep 28.

PMID:
30266751
10.

The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy.

Gui P, Ben-Neji M, Belozertseva E, Dalenc F, Franchet C, Gilhodes J, Labrousse A, Bellard E, Golzio M, Poincloux R, Maridonneau-Parini I, Le Cabec V.

Cancer Immunol Res. 2018 Nov;6(11):1337-1351. doi: 10.1158/2326-6066.CIR-17-0746. Epub 2018 Sep 4.

PMID:
30181209
11.

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker.

Gouazé-Andersson V, Ghérardi MJ, Lemarié A, Gilhodes J, Lubrano V, Arnauduc F, Cohen-Jonathan Moyal E, Toulas C.

Oncotarget. 2018 Aug 3;9(60):31637-31649. doi: 10.18632/oncotarget.25827. eCollection 2018 Aug 3.

12.

Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1.

Kowalski-Chauvel A, Modesto A, Gouaze-Andersson V, Baricault L, Gilhodes J, Delmas C, Lemarie A, Toulas C, Cohen-Jonathan-Moyal E, Seva C.

Cell Death Dis. 2018 Aug 29;9(9):872. doi: 10.1038/s41419-018-0853-x.

13.

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.

Rossi C, Gilhodes J, Maerevoet M, Herbaux C, Morschhauser F, Brice P, Garciaz S, Borel C, Ysebaert L, Obéric L, Lazarovici J, Deau B, Dupuis J, Chauchet A, Abraham J, Bijou F, Stamatoullas-Bastard A, Malfuson JV, Golfier C, Laurent C, Pericart S, Traverse-Glehen A, Kanoun S, Filleron T, Casasnovas RO, Ghesquières H.

Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25154. [Epub ahead of print]

14.

DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status.

Grgurevic S, Montilla-Perez P, Bradbury A, Gilhodes J, Queille S, Pelofy S, Bancaud A, Filleron T, Ysebaert L, Récher C, Laurent G, Fournié JJ, Cazaux C, Quillet-Mary A, Hoffmann JS.

Haematologica. 2018 Jun;103(6):1038-1046. doi: 10.3324/haematol.2017.174243. Epub 2018 Mar 22.

15.

Total body irradiation using Helical Tomotherapy®: Treatment technique, dosimetric results and initial clinical experience.

Sarradin V, Simon L, Huynh A, Gilhodes J, Filleron T, Izar F.

Cancer Radiother. 2018 Feb;22(1):17-24. doi: 10.1016/j.canrad.2017.06.014.

PMID:
29395854
16.

TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma.

Bertrand F, Montfort A, Marcheteau E, Imbert C, Gilhodes J, Filleron T, Rochaix P, Andrieu-Abadie N, Levade T, Meyer N, Colacios C, Ségui B.

Nat Commun. 2017 Dec 22;8(1):2256. doi: 10.1038/s41467-017-02358-7.

17.

[Nomograms in routine clinical practice: Methodology, interest and limitations].

Filleron T, Chaltiel L, Jouve E, Cabarrou B, Gilhodes J, Lusque A, Mery E, Dalenc F, Martinez A.

Bull Cancer. 2018 Jan;105(1):15-24. doi: 10.1016/j.bulcan.2017.10.024. Epub 2017 Dec 6. French.

PMID:
29221620
18.

Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Malric L, Monferran S, Gilhodes J, Boyrie S, Dahan P, Skuli N, Sesen J, Filleron T, Kowalski-Chauvel A, Cohen-Jonathan Moyal E, Toulas C, Lemarié A.

Oncotarget. 2017 Aug 21;8(49):86947-86968. doi: 10.18632/oncotarget.20372. eCollection 2017 Oct 17. Review.

19.

Comparison of variable selection methods for high-dimensional survival data with competing events.

Gilhodes J, Zemmour C, Ajana S, Martinez A, Delord JP, Leconte E, Boher JM, Filleron T.

Comput Biol Med. 2017 Dec 1;91:159-167. doi: 10.1016/j.compbiomed.2017.10.021. Epub 2017 Oct 20.

PMID:
29078093
20.

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial.

Gomez-Brouchet A, Illac C, Gilhodes J, Bouvier C, Aubert S, Guinebretiere JM, Marie B, Larousserie F, Entz-Werlé N, de Pinieux G, Filleron T, Minard V, Minville V, Mascard E, Gouin F, Jimenez M, Ledeley MC, Piperno-Neumann S, Brugieres L, Rédini F.

Oncoimmunology. 2017 Aug 24;6(9):e1331193. doi: 10.1080/2162402X.2017.1331193. eCollection 2017.

21.

Cell-assisted lipotransfer: Friend or foe in fat grafting? Systematic review and meta-analysis.

Laloze J, Varin A, Gilhodes J, Bertheuil N, Grolleau JL, Brie J, Usseglio J, Sensebe L, Filleron T, Chaput B.

J Tissue Eng Regen Med. 2018 Feb;12(2):e1237-e1250. doi: 10.1002/term.2524. Epub 2017 Dec 7.

PMID:
28719946
22.

Sphingosine 1-phosphate signaling through its receptor S1P5 promotes chromosome segregation and mitotic progression.

Andrieu G, Ledoux A, Branka S, Bocquet M, Gilhodes J, Walzer T, Kasahara K, Inagaki M, Sabbadini RA, Cuvillier O, Hatzoglou A.

Sci Signal. 2017 Mar 28;10(472). pii: eaah4007. doi: 10.1126/scisignal.aah4007.

PMID:
28351953
23.

Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells.

Wang YY, Attané C, Milhas D, Dirat B, Dauvillier S, Guerard A, Gilhodes J, Lazar I, Alet N, Laurent V, Le Gonidec S, Biard D, Hervé C, Bost F, Ren GS, Bono F, Escourrou G, Prentki M, Nieto L, Valet P, Muller C.

JCI Insight. 2017 Feb 23;2(4):e87489. doi: 10.1172/jci.insight.87489.

24.

Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.

Gilhodes JC, Julé Y, Kreuz S, Stierstorfer B, Stiller D, Wollin L.

PLoS One. 2017 Jan 20;12(1):e0170561. doi: 10.1371/journal.pone.0170561. eCollection 2017.

25.

[Subgroup analysis and forest plots: Limitations and interests].

Filleron T, Gilhodes J, Delord JP, Cabarrou B.

Bull Cancer. 2017 Jan;104(1):92-100. doi: 10.1016/j.bulcan.2016.09.023. Epub 2016 Nov 4. Review. French.

PMID:
27823809
26.

Statistical controversies in clinical research: should schedules of tumor size assessments be changed?

Filleron T, Kouokam W, Gilhodes J, Duhamel A, Penel N, Joly F, Tresch-Bruneel E, Kramar A, Houédé N.

Ann Oncol. 2016 Nov;27(11):1981-1987. Epub 2016 Aug 8. Review.

PMID:
27502711
27.

Incidence of major smoking-related cancers: trends among adults aged 20-44 in France from 1982 to 2012.

Gilhodes J, Belot A, Bouvier AM, Remontet L, Delafosse P, Ligier K, Rogel A.

Cancer Epidemiol. 2015 Oct;39(5):707-13. doi: 10.1016/j.canep.2015.07.001. Epub 2015 Jul 22.

28.

Qualitative and quantitative analysis of tachykinin NK2 receptors in chemically defined human colonic neuronal pathways.

Jaafari N, Khomitch-Baud A, Gilhodes JC, Hua G, Julé Y.

J Comp Neurol. 2008 Apr 1;507(4):1542-58. doi: 10.1002/cne.21628.

PMID:
18219665
29.

Learning through hand- or typewriting influences visual recognition of new graphic shapes: behavioral and functional imaging evidence.

Longcamp M, Boucard C, Gilhodes JC, Anton JL, Roth M, Nazarian B, Velay JL.

J Cogn Neurosci. 2008 May;20(5):802-15. doi: 10.1162/jocn.2008.20504.

PMID:
18201124
30.

Remembering the orientation of newly learned characters depends on the associated writing knowledge: a comparison between handwriting and typing.

Longcamp M, Boucard C, Gilhodes JC, Velay JL.

Hum Mov Sci. 2006 Oct;25(4-5):646-56. Epub 2006 Oct 2.

PMID:
17011660
31.

Antagonist motor responses correlate with kinesthetic illusions induced by tendon vibration.

Calvin-Figuière S, Romaiguère P, Gilhodes JC, Roll JP.

Exp Brain Res. 1999 Feb;124(3):342-50.

PMID:
9989440
32.

From balance regulation to body orientation: two goals for muscle proprioceptive information processing?

Kavounoudias A, Gilhodes JC, Roll R, Roll JP.

Exp Brain Res. 1999 Jan;124(1):80-8.

PMID:
9928792
33.

Proprioceptive information processing in weightlessness.

Roll R, Gilhodes JC, Roll JP, Popov K, Charade O, Gurfinkel V.

Exp Brain Res. 1998 Oct;122(4):393-402.

PMID:
9827858
34.

Vibration-induced postural posteffects.

Wierzbicka MM, Gilhodes JC, Roll JP.

J Neurophysiol. 1998 Jan;79(1):143-50.

35.

Human motor unit activity during post-vibratory and imitative voluntary muscle contractions.

Ribot-Ciscar E, Roll JP, Gilhodes JC.

Brain Res. 1996 Apr 15;716(1-2):84-90.

PMID:
8738223
36.
37.

Propriomuscular coding of kinaesthetic sensation. Experimental approach and mathematical modelling.

Gilhodes JC, Coiton Y, Roll JP, Ans B.

Biol Cybern. 1993;68(6):509-17.

PMID:
8324059
38.

Sensorimotor and perceptual function of muscle proprioception in microgravity.

Roll JP, Popov K, Gurfinkel V, Lipshits M, André-Deshays C, Gilhodes JC, Quoniam C.

J Vestib Res. 1993 Fall;3(3):259-73.

PMID:
8275261
39.

Role of Ia muscle spindle afferents in post-contraction and post-vibration motor effect genesis.

Gilhodes JC, Gurfinkel VS, Roll JP.

Neurosci Lett. 1992 Feb 3;135(2):247-51.

PMID:
1625803
40.

A neural network model for the intersensory coordination involved in goal-directed movements.

Coiton Y, Gilhodes JC, Velay JL, Roll JP.

Biol Cybern. 1991;66(2):167-76.

PMID:
1768721
41.

Induction of illusory limb movement as a means of studying sensorimotor interactions in the eye-arm system.

Tardy-Gervet MF, Gilhodes JC, Roll JP.

Brain Behav Evol. 1989;33(2-3):165-70.

PMID:
2527076
42.

Forearm vs whole-body sensations of self-motion: some results on the role of the sensorimotor context.

Tardy-Gervet MF, Gilhodes JC, Roll JP.

Percept Mot Skills. 1988 Oct;67(2):351-8.

PMID:
3217179
43.

Interactions between visual and muscular information in illusions of limb movement.

Tardy-Gervet MF, Gilhodes JC, Roll JP.

Behav Brain Res. 1986 May;20(2):161-74.

PMID:
3730131
44.

Perceptual and motor effects of agonist-antagonist muscle vibration in man.

Gilhodes JC, Roll JP, Tardy-Gervet MF.

Exp Brain Res. 1986;61(2):395-402.

PMID:
3948946
45.

Perceptual and motor effects elicited by a moving visual stimulus below the forearm: an example of segmentary vection.

Tardy-Gervet MF, Gilhodes JC, Roll JP.

Behav Brain Res. 1984 Feb;11(2):171-84.

PMID:
6704236
46.

[Simulation of neuronal networks (SIRENE). I. The model].

Ans B, Gilhodes JC.

C R Seances Acad Sci III. 1983;297(7):361-4. French.

PMID:
6420009
48.
49.

[Perceptive and motor effects of muscular vibrations in the normal human: demonstration of a response by opposing muscles].

Roll JP, Gilhodes JC, Tardy-Gervet MF.

Arch Ital Biol. 1980 Mar;118(1):51-71. French. No abstract available.

PMID:
7458531
50.

[Effects of vision on tonic vibration response of a muscle or its antagonists in normal man (author's transl)].

Roll JP, Gilhodes JC, Tardy-Gervet MF.

Experientia. 1980 Jan 15;36(1):70-2. French.

PMID:
6444589

Supplemental Content

Loading ...
Support Center